🇺🇸 FDA
Company

Entrada

Entrada Therapeutics

TRDA pharma USA

Quick answer

Entrada is a pharma company (TRDA) headquartered in BOSTON, MA, USA with 2 tracked pipeline programs.

Pipeline (2)

project

ENTR-601-44

Duchenne Muscular Dystrophy (DMD)

Phase 2 · small_molecule · active

1 trials project

ENTR-601-45

Duchenne Muscular Dystrophy (DMD)

Phase 2 · small_molecule · active

1 trials

Patents (5)

patent

US 11987821

Compositions and methods for treating mitochondrial neurogastrointestinal enceph

Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11225506

Cell penetrating peptides and methods of making and using thereof

Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11168310

Compositions and methods for treating mitochondrial neurogastrointestinal enceph

Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10815276

Cell penetrating peptides and methods of making and using thereof

Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10626147

Cell penetrating peptides and methods of making and using thereof

Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)